Business Investment Opportunities

UAE-based smart, transparent and tech-driven investment platform operating since 11 years, connecting private investors with high-potential, asset-backed business opportunities. - Strong promoter background with 11+ years in investment management, business incubation and venture growth across global markets. - Community of 158+ private investors and an active portfolio of 39+ businesses across logistics, robotics, manufacturing, container leasing, fintech and other asset-backed sectors. - Revenue model combines profit-sharing, equity participation and operational income from real assets, offering diversified and transparent returns. - Global presence across UAE, India, Malaysia, USA, Australia, Canada and Europe supported by long-term partnerships with founders and enterprises. - Team of 37 professionals across investment analysis, project management, finance, marketing and operations. - Operates with a valid business registration certificate.

Operates an enterprise-focused AI adoption platform that helps companies build and integrate their own AI systems while ensuring all data remains securely within the organization. - Specializes in developing custom AI architectures, enterprise-grade automation, and tailored machine-learning solutions built to meet internal workflow and compliance needs. - Has served 19 clients to date, demonstrating strong delivery capability, with 2 active clients currently using the platform on an ongoing basis. - Positioned as “AI building AI” enabling businesses to accelerate digital transformation through scalable, maintainable, and secure AI implementation. - Over five years of operational experience, backed by technical expertise in enterprise AI design and deployment. - Holds a valid GST registration and certificate of incorporation, ensuring compliant and structured service operations.

Operates an enterprise-focused AI adoption platform that helps companies build and integrate their own AI systems while ensuring all data remains securely within the organization. - Specializes in developing custom AI architectures, enterprise-grade automation, and tailored machine-learning solutions built to meet internal workflow and compliance needs. - Has served 19 clients to date, demonstrating strong delivery capability, with 2 active clients currently using the platform on an ongoing basis. - Positioned as “AI building AI” enabling businesses to accelerate digital transformation through scalable, maintainable, and secure AI implementation. - Over five years of operational experience, backed by technical expertise in enterprise AI design and deployment. - Holds a valid GST registration and certificate of incorporation, ensuring compliant and structured service operations.

The business is a book publisher that sells language-learning books in English, Hindi, and Marathi, as well as handwriting improvement books. - Our revenue comes from the sale of these books. Most sales take place offline across India through 20 franchise partners. - Online sales are made through Amazon and Flipkart. - All books are written and copyrighted by the founder. - We work with a third-party printing house to produce our books. - The business employs seven permanent staff who manage the technical operations. - The business operates as a sole proprietorship with GST registration.

IVD medical device manufacturing company with established domestic and international presence. - Serves 150 active customers through a pan-India distribution network and exports to 36 countries. - Operating at 20% production capacity utilization, offering significant scale-up potential. - Team of 90 employees managing manufacturing, quality control, and distribution. - Factory located on a 2.4-acre owned industrial property. - Inventory worth INR 10 crore is included; ISO certification, GST registration, and company incorporation are in place. - Physical asset base valued at INR 35 crore. - Private limited company established over a decade ago with 3 shareholders and a project loan of INR 20 crore. - Promoter seeking partial stake sale for growth capital.

The company is a retailer of medical devices and diagnostic systems. - Its top-selling products include hospital beds and MRI scanning devices. - The business serves 15 government hospitals in Zambia and sources products from dealers in China, Korea, and Australia. - Approximately 80% of revenue comes from medical equipment retail, while the remaining 20% is generated through the company acting as a building contractor for specific projects. - We have 3 permanent employees who ensure smooth operations. - The owner is based in Australia and can be contacted directly through the provided number.

Located in Central Hong Kong, the clinic specializes in advanced health treatments, focusing primarily on IV drips, Ozempic, and blood tests. - IV drips are the top-selling product, accounting for 70% of the clinic's revenue, catering to customers seeking hydration and nutrient therapy. - Ozempic, a medication used for weight management and diabetes control, represents 20% of sales, appealing to patients looking for effective health solutions. - Blood tests contribute to 10% of the clinic's sales, providing essential diagnostics for preventive health care and monitoring various medical conditions. - The clinic attracts approximately 100-200 customers per month, establishing a loyal customer base in the competitive healthcare market. - With strong sales and profitability, the clinic effectively meets the growing demand for outpatient health services in Hong Kong. - Utilizing innovative treatments and a customer-centric approach, the clinic positions itself as a leading health provider in the region, maximizing revenue through high-demand services. - Holds and operates with a valid clinic license.

This global biotechnology company specializes in cutting-edge allogeneic adult stem cell technology, uniquely positioned as the only FDA-approved entity worldwide, with the Drug Controller General of India (DCGI) approval in process. - The company manufactures clinical-grade stem cells under cGMP standards, providing vital materials for US-based and international clinical trials, hence establishing a strong foothold in the biotechnology sector. - With Investigational New Drug Approvals for several serious conditions, including acute myocardial infarction, chronic heart failure, and Alzheimer’s disease, the company focuses on innovative solutions for chronic ailments lacking effective treatments. - Its cell-based therapies are designed to enhance longevity and quality of life, particularly targeting rehabilitation for chronic stroke patients and those affected by diseases without available cures. - Operating for 24 years in California, the business has a robust track record and is actively seeking expansion opportunities in international markets, allowing for broader reach and impact. - Revenue is generated through multiple channels, including a sale of license model with annual royalty fees averaging around 15% revenue, alongside direct sales of stem cells to existing licensees that partner with hospitals and healthcare providers. - Major license sale deals over the years include up to $18 million (₹162.7 crore) with a Chinese firm, $28 million (₹253 crore) with a Mexican company, $20 million (₹180.7 crore) with a Russian entity, and $21 million (₹189.8 crore) with a Kazakh company, showcasing strong demand and financial viability. - Recently registered as a public limited company in India, the firm is planning to establish a local laboratory and operations, further strengthening its market presence in the biotechnology industry. - The workforce comprises around 50 full-time employees, supplemented by freelance and interns, enhancing operational flexibility and innovation in research and development. - The promoter is currently in India and oversees operations across both locations.